Descriptor English: | Myasthenia Gravis, Neonatal | ||||||
Descriptor Spanish: |
Miastenia Gravis Neonatal
| ||||||
Descriptor Portuguese: | Miastenia Gravis Neonatal | ||||||
Descriptor French: | Myasthénie congénitale | ||||||
Entry term(s): |
Antenatal Myasthenia Gravis Myasthenia Gravis, Antenatal Myasthenia Gravis, Neonatal, Persistent Myasthenia Gravis, Neonatal, Transient Myasthenia Gravis, Persistent, Neonatal Myasthenia Gravis, Transient, Neonatal Neonatal Myasthenia Gravis Neonatal Myasthenia Gravis, Persistent Neonatal Myasthenia Gravis, Transient Persistent Neonatal Myasthenia Gravis Transient Neonatal Myasthenia Gravis |
||||||
Tree number(s): |
C10.114.656.650 C10.668.758.725.650 C20.111.258.500.650 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D020941 | ||||||
Scope note: | A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves (i.e., transient neonatal myasthenia gravis) although this disorder may rarely continue beyond the neonatal period (i.e., persistent neonatal myasthenia gravis). (From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48(1):50-4) |
||||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
Previous Indexing: |
Myasthenia Gravis (1965-1999) |
||||||
Public MeSH Note: | 2000 |
||||||
History Note: | 2000 |
||||||
DeCS ID: | 34210 | ||||||
Unique ID: | D020941 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2000/01/01 | ||||||
Date of Entry: | 1999/11/03 |
|
Myasthenia Gravis, Neonatal
- Preferred
Myasthenia Gravis, Neonatal, Persistent
- Narrower
Antenatal Myasthenia Gravis
- Narrower
Myasthenia Gravis, Neonatal, Transient
- Narrower
Concept UI |
M0328228 |
Scope note | A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves (i.e., transient neonatal myasthenia gravis) although this disorder may rarely continue beyond the neonatal period (i.e., persistent neonatal myasthenia gravis). (From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48(1):50-4) |
Preferred term | Myasthenia Gravis, Neonatal |
Entry term(s) |
Neonatal Myasthenia Gravis |
Concept UI |
M0335262 |
Preferred term | Myasthenia Gravis, Neonatal, Persistent |
Entry term(s) |
Myasthenia Gravis, Persistent, Neonatal Neonatal Myasthenia Gravis, Persistent Persistent Neonatal Myasthenia Gravis |
Concept UI |
M0335261 |
Preferred term | Antenatal Myasthenia Gravis |
Entry term(s) |
Myasthenia Gravis, Antenatal |
Concept UI |
M0335263 |
Preferred term | Myasthenia Gravis, Neonatal, Transient |
Entry term(s) |
Myasthenia Gravis, Transient, Neonatal Neonatal Myasthenia Gravis, Transient Transient Neonatal Myasthenia Gravis |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey